Background. Liposarcoma of the head and neck region represents approxi
mately 1% of head and neck sarcomas. Therefore, there are few data on
the natural history, presentation, treatment, and prognosis of this ne
oplasm. Methods. This study is a report of data from 76 patients with
head and neck liposarcoma of whom 4 were treated at The Royal Marsden
Hospital during the past 50 years. Results. The median age of patient
presentation was the seventh decade (range, 6 months-86 years), and 65
% of the patients were male. The commonest site of presentation was th
e neck (28%), followed by the larynx (20%) and pharynx (18%). Sixty-tw
o percent of tumors were low grade (well differentiated and myxoid), a
nd 38% were high grade (pleomorphic and round cell). The principal det
erminant of outcome was histologic grade. Five-year survival by life-t
able analysis was 67% overall and varied with tumor type as follows: w
ell differentiated 100%, myxoid 73%, pleomorphic 42%, and round cell 0
%. Site appears to have had some influence on prognosis. Oral liposarc
oma had a poor prognosis with a 5-year survival of 50%, despite the lo
w grade of all tumors; however, the 5-year survival for laryngeal (89%
) and head (83%) liposarcoma was considerably better. Tumor size did n
ot affect prognosis. The mainstay of treatment was surgical excision,
used alone in 70% of the cases. Radiotherapy was used with other treat
ments in 25% of the cases, Prognosis was best for patients treated wit
h surgery only (5-year survival, 83%), compared with those receiving s
urgery plus radiotherapy (5-year survival, 63%), chemotherapy (5-year
survival, 33%), and radiotherapy alone (5-year survival, 0%). Complete
surgical excision provides the most effective treatment. Conclusions.
Liposarcoma rarely involves the head and neck region. The prognosis f
or patients with this disease appears to be better than for those with
liposarcoma arising elsewhere, particularly in the retroperitoneum. P
rognosis is principally dependent on histologic grade.